CID 16131966

Hiv-1 12-mer tar rna containing 2'-o-methyl and 2',4'-locked nucleotides: [5'-lna(c)-2'-ome(u)-(s)-lna(c)-2'-ome(c)-(s)-lna(c)-2'-ome(a)-2'-ome(g)-2'-ome(g)-(s)-lna(c)-2'-ome(u)-(s)-lna(c)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C154H186N44O88P12S4
SMILES
CC1=CN(C(=O)N=C1N)C2C3C(C(O2)(CO3)CO)OP(=O)(O)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)OC)OP(=S)(O)OCC67COC(C6OP(=O)(O)OCC8C(C(C(O8)N9C=CC(=NC9=O)N)OC)OP(=S)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C(N=CN=C31)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=S)(O)OCC13COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=O)(OCC14COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC5=C(N=CN=C51)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC5=C(C=C1)C(=O)OC51C5=C(C=C(C=C5)O)OC5=C1C=CC(=C5)O)C(O4)N1C=C(C(=NC1=O)N)C)S)C(O3)N1C=C(C(=NC1=O)N)C)C(O2)N1C=C(C(=NC1=O)N)C)C(O7)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C154H186N44O88P12S4/c1-58-30-190(144(212)178-111(58)156)133-101-106(149(42-199,269-133)43-244-101)282-290(223,224)254-39-77-91(98(241-10)127(263-77)188-24-20-81(202)176-142(188)210)279-296(234,300)259-50-152-46-247-104(136(272-152)193-33-61(4)114(159)181-147(193)215)109(152)285-293(229,230)255-40-76-90(97(240-9)126(262-76)187-23-19-80(155)175-141(187)209)278-295(233,299)257-48-150-44-246-103(135(270-150)192-32-60(3)113(158)180-146(192)214)108(150)284-292(227,228)253-37-75-88(95(238-7)130(266-75)196-55-171-84-117(162)167-53-169-120(84)196)276-288(219,220)250-35-73-89(96(239-8)131(267-73)197-56-172-85-121(197)183-139(164)185-124(85)206)277-289(221,222)251-38-79-93(100(243-12)132(268-79)198-57-173-86-122(198)184-140(165)186-125(86)207)281-298(236,302)260-51-153-47-248-105(137(273-153)194-34-62(5)115(160)182-148(194)216)110(153)286-294(231,232)256-41-78-92(99(242-11)128(264-78)189-25-21-82(203)177-143(189)211)280-297(235,301)258-49-151-45-245-102(134(271-151)191-31-59(2)112(157)179-145(191)213)107(151)283-291(225,226)252-36-74-87(94(237-6)129(265-74)195-54-170-83-116(161)166-52-168-119(83)195)275-287(217,218)249-26-22-70(118(163)204)174-123(205)63-13-16-66-69(27-63)154(274-138(66)208)67-17-14-64(200)28-71(67)261-72-29-65(201)15-18-68(72)154/h13-21,23-25,27-34,52-57,70,73-79,87-110,126-137,199-201H,22,26,35-51H2,1-12H3,(H2,163,204)(H,174,205)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H,227,228)(H,229,230)(H,231,232)(H,233,299)(H,234,300)(H,235,301)(H,236,302)(H2,155,175,209)(H2,156,178,212)(H2,157,179,213)(H2,158,180,214)(H2,159,181,215)(H2,160,182,216)(H2,161,166,168)(H2,162,167,169)(H,176,202,210)(H,177,203,211)(H3,164,183,185,206)(H3,165,184,186,207)/t70-,73?,74?,75?,76?,77?,78?,79?,87?,88?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,109?,110?,126?,127?,128?,129?,130?,131?,132?,133?,134?,135?,136?,137?,149?,150?,151?,152?,153?,295?,296?,297?,298?/m0/s1
InChIKey
PHUBJILRQRXHHY-COQZHHLVSA-N
Compound name
[3-[[7-[[3-[[7-[[3-[[3-[[3-[[7-[[3-[[7-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-sulfanylphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methyl [3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4558.717 Da
Monoisotopic Mass

-23.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4559.7243 312.1
[M+Na]+ 4581.7062 312.4
[M-H]- 4557.7097 312.2
[M+NH4]+ 4576.7508 312.2
[M+K]+ 4597.6802 312.2
[M+H-H2O]+ 4541.7143 312.0
[M+HCOO]- 4603.7152 312.2
[M+CH3COO]- 4617.7309 312.2
[M+Na-2H]- 4579.6917 312.5
[M]+ 4558.7165 312.4
[M]- 4558.7175 312.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.